Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 3,985 filings

Top spenders & firms Spend by issue

Clear
Q1
BROWNSTEIN HYATT FARBER SCHRECK, LLP for GRINDR LLC
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income
Health Issues, Science/Technology
View →
Q1
ENERGY MARKETERS OF AMERICA for ENERGY MARKETERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Tobacco, Environment/Superfund, Disaster Planning/Emergencies, Labor Issues/Antitrust/Workplace
View →
Q1
UNILEVER UNITED STATES, INC. for UNILEVER UNITED STATES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Environment/Superfund, Food Industry (safety, labeling, etc.), Consumer Issues/Safety/Products, Health Issues
View →
Q1
BANNER PUBLIC AFFAIRS, LLC for THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $20,000.00 income
Defense, Health Issues
View →
Q1
K&L GATES, LLP for THE FIRST CHURCH OF CHRIST, SCIENTIST
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Defense, Taxation/Internal Revenue Code
View →
Q1
TROUTMAN STRATEGIES for CIVITAS NETWORKS FOR HEALTH (FKA CIVITAS NETWORKS FOR HEALTH ASSOCIATION)
1st Quarter (Jan 1 - Mar 31) 2026 · Colorado · House · Senate · $40,000.00 income
Health Issues
View →
Q1
DCI GROUP, L.L.C. for VAXCYTE, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · $75,000.00 income
Health Issues
View →
Q1
DCI GROUP, L.L.C. for DOORDASH
1st Quarter (Jan 1 - Mar 31) 2026 · California · $60,000.00 income
Labor Issues/Antitrust/Workplace, Health Issues
View →
Q1
CFM STRATEGIC COMMUNICATIONS (CONKLING FISKUM & MCCORMICK) for PEACE HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · Washington · House · Senate · $10,000.00 income
Health Issues, Labor Issues/Antitrust/Workplace
View →
Q1
TROUTMAN STRATEGIES for LEIDOS HOLDINGS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $40,000.00 income
Health Issues, Defense, Budget/Appropriations
View →
Q1
TROUTMAN STRATEGIES for THE SEQUOIA PROJECT (FORMERLY HEALTHEWAY, INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $60,000.00 income
Health Issues
View →
Q1
TROUTMAN STRATEGIES for CORPORATE FRIENDS OF CDC, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income
Budget/Appropriations, Health Issues
View →
Q1
TROUTMAN STRATEGIES for CALIFORNIA LEAFY GREEN PRODUCTS HANDLER MARKETING AGREEMENT
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income
Agriculture, Food Industry (safety, labeling, etc.), Health Issues
View →
Q1
NATIONAL ADVOCACY CENTER OF THE SISTERS OF THE GOOD SHEPHERD for CONFERENCE OF PROVINCIALS OF NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Missouri · House · Senate · $20,000.00 income
Law Enforcement/Crime/Criminal Justice, Immigration, Budget/Appropriations, Foreign Relations
View →
Q1
TOWNSEND PUBLIC AFFAIRS, INC for COUNTY OF ORANGE
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income
Budget/Appropriations, Housing, Transportation, Clean Air and Water (quality)
View →
Q1
SHIONOGI INC. for SHIONOGI INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Insurance
View →
Q1
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS for ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Health Issues
View →
Q1
CAPITOL STRATEGIES, LLC for BIOLAB HOLDINGS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $20,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q1
FORBES-TATE for IONIS PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
FORBES-TATE for HALOZYME THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
FORBES-TATE for GRAIL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
FORBES-TATE for GLOBAL MEDICAL RESPONSE
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Disaster Planning/Emergencies
View →
Q1
CAPITOL COUNSEL LLC for BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign), Budget/Appropriations
View →
Q1
FORBES-TATE for GILEAD SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $90,000.00 income
Health Issues
View →
Q1
HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $50,000.00 income
Health Issues, Pharmacy, Budget/Appropriations
View →
Previous Page 93 of 160 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem